Abivax SA Stock Forecast
NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ABVX analyst consensus
Consensus (12 analysts)
strong_buy
Avg. price target
$164.00+88.48%
- Strong buy 4
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Abivax SA (2026-10-07), 12 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $164.00, with a high estimate of $181.00 and a low estimate of $142.00. The average target implies upside of 88.5% from the current price of $87.01.
The spread between the highest and lowest targets is 27.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ABVX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 4 | 33% |
| Buy | 8 | 67% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $142.00 | +63.20% |
| Average target | $164.00 | +88.48% |
| High target | $181.00 | +108.02% |